Optic Nerve transection is a widely used model of adult CNS injury. Ninety percent of retinal ganglion cells (RGCs) whose axons are completely transected (axotomy) die within 14 days after axotomy. This model is easily amenable to experimental manipulations and highly reproducible.
Cite this ArticleCopy Citation
Magharious, M. M., D'Onofrio, P. M., Koeberle, P. D. Optic Nerve Transection: A Model of Adult Neuron Apoptosis in the Central Nervous System. J. Vis. Exp. (51), e2241, doi:10.3791/2241 (2011).
Translate text to:
Retinal ganglion cells (RGCs) are CNS neurons that output visual information from the retina to the brain, via the optic nerve. The optic nerve can be accessed within the orbit of the eye and completely transected (axotomized), cutting the axons of the entire RGC population. Optic nerve transection is a reproducible model of apoptotic neuronal cell death in the adult CNS 1-4. This model is particularly attractive because the vitreous chamber of the eye acts as a capsule for drug delivery to the retina, permitting experimental manipulations via intraocular injections. The diffusion of chemicals through the vitreous fluid ensures that they act upon the entire RGC population. Moreover, RGCs can be selectively transfected by applying short interfering RNAs (siRNAs), plasmids, or viral vectors to the cut end of the optic nerve 5-7 or injecting vectors into their target, the superior colliculus 8. This allows researchers to study apoptotic mechanisms in the desired neuronal population without confounding effects on other bystander neurons or surrounding glia. An additional benefit is the ease and accuracy with which cell survival can be quantified after injury. The retina is a flat, layered tissue and RGCs are localized in the innermost layer, the ganglion cell layer. The survival of RGCs can be tracked over time by applying a fluorescent tracer (3% Fluorogold) to the cut end of the optic nerve at the time of axotomy, or by injecting the tracer into the superior colliculus (RGC target) one week prior to axotomy. The tracer is retrogradely transported, labeling the entire RGC population. Because the ganglion cell layer is a monolayer (one cell thick), RGC densities can be quantified in flat-mounted tissue, without the need for stereology. Optic nerve transection leads to the apoptotic death of 90% of injured RGCs within 14 days postaxotomy 9-11. RGC apoptosis has a characteristic time-course whereby cell death is delayed 3-4 days postaxotomy, after which the cells rapidly degenerate. This provides a time window for experimental manipulations directed against pathways involved in apoptosis.
1. Surgical Technique
- Experiments should be carried out using aseptic technique and following the animal use protocols of your specific institution. Instruments and materials (solutions, test substances, tracers, needles, etc.) coming into contact with living tissue must be sterile to prevent infection and adverse impacts on animal welfare and potential negative impacts on the study.
- Rats will be anaesthetized using a veterinary isoflurane vaporizer system. Use medical grade oxygen at a rate of 0.8 L/min to vaporize the isoflurane gas. Place the animal in the attached anesthesia box and dial in an isoflurane concentration of 4% until the breathing has slowed and the animal is sedate.
- Next, switch the gas flow to the gas mask attachment for the stereotaxic frame and place the animal in the stereotaxic apparatus. Turn the isoflurane concentration down to 2% and monitor anesthesia. Larger animals (>300g) may require a higher concentration of isoflurane. Anesthesia should be monitored during surgery and isoflurane dosage adjusted accordingly. Depth and rate of breathing should be constantly evaluated, and toe pinch evaluation (every 5 min) for the absence of deep pain should be performed.
- Once the surgery is complete, turn off the isoflurane and allow the animal to breath oxygen for several minutes prior to removal from the stereotaxic device. Body temperature should be maintained by covering the animal with a surgical blanket and/or using a regulated heating blanket during surgery.
3. Surgical Approach
- Wet the fur on top of the head with 70% ethanol to make the fur easier to cut. Remove the fur from between the eyes using a clipper or sharp scissors. Clean the incision area three times with alternating applications of iodine detergent solution (Proviodine, Betadine, etc) followed by 70% ethanol. Maintain the cornea moist throughout the surgery by applying ophthalmic eye ointment (Tears Naturale P.M.) to the cornea. Spread the ointment over the surface of the cornea by manually opening and closing the eyelids.
- Using a No. 11 blade, make an incision along the midline of the head from approximately 0.5 cm in front of the eyes to 1 cm behind the eyes. Retract the flap of skin over the eye using forceps and gently tease away the underlying connective tissue with the back of the scalpel. Then, retract the flap of skin laterally and downward and hold in place with a surgical retractor that can be taped to the base of the stereotaxic instrument.
- Make an incision along the superior rim of the orbital bone while pulling on the overlying fascia with sharp forceps. This will withdraw the fascia overlying the orbit of the eye. The rim of the orbital bone can be clearly demarcated by using forceps to push down on the fascia overlying the orbit. Using a cautery device or scalpel, continue the incision backwards towards the posterior limit of the orbit of the eye. Use the bone of the superior orbit as a guide for the incision. Next continue the incision forwards toward the anterior limit of the orbit. The incision of the superior orbit is best done using a small cautery device in order to prevent bleeding from the underlying vessels that communicate with the venous sinuses.
- If bleeding occurs several steps can be taken. Firstly, apply pressure using sterile surgical swabs or cotton swabs. If bleeding continues, apply cold, sterile phosphate buffer saline (PBS) to the area using a dropper, and maintain pressure. Minor bleeding will stop after several seconds using this procedure. If bleeding persists, apply traction to the tissue with the surgical swab or cotton swab in order to identify the source of bleeding and rapidly cauterize the compromised vessel. After the bleeding is contained, use cold sterile PBS to clean the surgical area of blood. The surgical area should be periodically cleaned in this fashion in order to better visualize structures in the orbit of the eye.
- Once the incision has been cleaned, use forceps and the back of the scalpel to clean the connective tissue at the back of the eye that overlies the orbital contents. The back of the No. 11 scalpel works well as the tip is fine. This will open up deeper portions of the orbital cavity providing a larger surgical window to work in. Use Dumont #7b sharp-curved-serrated forceps when working in the eye as their curvature and fine tips are ideal for manipulating structures in the orbit. Furthermore, the serrations help with gripping structures.
- Next, remove the connective tissue that surrounds the ophthalmic division of the trigeminal nerve which sits near the midline, and remove the nerve using forceps. This step is not necessary, however removing the nerve will provide a larger window of access to the optic nerve later on.
- Following removal of the nerve, use forceps to retract the blood vessel below and completely cauterize the vessel. This step is also not necessary, however cautery of the vessel allows it to be moved anteriorly, thereby creating a larger window once the optic nerve is reached.
- Use a sharp pair of forceps, or forceps that have had their tips bent inward to carefully pick and remove the thin layer of connective tissue over the extraocular muscles and lacrimal gland. Retract the extra ocular muscles from anterior to posterior of the orbit. Grip the proximal part of the muscle with a pair of forceps and use a second pair of curved serrated eye dressing forceps to apply outward traction on the muscle. Make sure that the eye dressing forceps are oriented in the same direction as the muscle when pulling in order to prevent tearing. Remove the most anterior muscle of the orbit (Superior Oblique) in this manner. The muscle will be liberated from deep within the orbit and the remaining length can be retracted in order to rotate the eye outward.
- Repeat Step 3.8 with the next muscle (Medial Rectus) that is located between the lobes of the lacrimal gland and Harderian Gland near the midline of the dorsal surface of the eye. Tape down the retractor to maintain traction on the muscles.
- Gently remove any remaining connective tissue over the surface of the lacrimal gland and lift the gland upward using forceps. Do not compress or squeeze the gland. In order to retract the gland, only a single vessel at the posterior pole needs to be cauterized. Lift the posterior end of the gland upward, and then cauterize the vessel.
- Next, flap the lacrimal gland forward to open the posterior part of the orbit and allow unimpeded access to the muscles that overlie the optic nerve. Keep the area constantly moist using sterile PBS, and drying with surgical swabs or cotton swabs.
- Using sharp forceps once again remove the thin connective tissue that surrounds the muscles of the posterior orbit (Levator Palpebrae Superioris and Superior Rectus) and separate the underlying bundles of muscle. Retract the muscles independently or in unison, using the curved serrated eye dressing forceps, once again, pulling in line with the muscle fibers. Attach the remaining muscle lengths to the retractor along with the muscles that were retracted in Steps 3.8 and 3.9 and tape down the retractor to apply traction. A total of 4 muscles will now be attached to the retractor. This will rotate the eye forward and outward in order to reveal the fat containing sheath that surrounds the optic nerve.
4. Accessing the Optic Nerve
- Use sharp forceps (Fine tip Dumont) to pull upward on the connective tissue that surrounds the fatty sheath of the optic nerve. Make a longitudinal cut using small Vannas spring scissors. Expand the cut as necessary. The fat contained by the sheath will begin to bulge out once the cut is made. Next remove the flaps of connective tissue by carefully pulling upward from the edge and cutting off the crescent shaped flaps of tissue.
- Remove the fat overlying the optic nerve by using forceps to pull on the fat, while cutting with the Vannas spring scissors. Keep the area clean using sterile PBS and surgical swabs to clean the small amounts of blood that arise from the removal of the tissue.
- The optic nerve is now visible. In order to access the nerve, the meningeal sheath that surrounds the nerve must be removed without damaging the ophthalmic artery which feeds the inner retina. Examine the vascular pattern of the meningeal sheath using forceps to gently rotate the sheath. Look for an area devoid of blood vessels, and permitting a longitudinal cut to be made in the meningeal sheath.
- Using fine tip Dumont forceps, pinch the dura and pull upward. Near the base of the triangular shaped wedge of dura that is created, use the Vannas spring scissors to make a small incision in the sheath. Insert the lower blade of the scissors into the incision and cut the sheath parallel to the direction of the optic nerve, careful not to damage the vasculature with lateral cuts. Use the forceps and scissors to drape the dura to either side of the optic nerve.
- The only remaining covering of the nerve is the arachnoid membrane. It is very thin and transparent. In order to determine if the membrane is still present, use sharp forceps to pinch the surface of the nerve. It the arachnoid is present, pinch the membrane and pull upward to create a triangular wedge of tissue. Make a small incision with the tip of the scissors similar to Step 4.4. Then, insert the lower blade of the scissors and make a longitudinal cut in the arachnoid. Next, use your scissors and forceps to drape the arachnoid to either side of the optic nerve.
- Using a micro-surgical hook, elevate the optic nerve out of the meningeal sheath. Pass the tip of the hook around the outer edge of the nerve and make sure that the hook stays in contact with the nerve so that you do not catch the meningeal membranes with the hook and accidentally transect them. Gently lift the optic nerve out of the meningeal sheath and completely transect the nerve behind the point supported by the hook. The transected optic nerve stump will now have a free end, allowing for the removal of the hook.
- If the RGCs are going to be retrogradely labeled in order to quantify survival, place a small piece of gelfoam soaked in 3% Fluorogold (or another retrograde tracer) over the transected optic nerve stump (see JoVE protocol 2261).
5. Closing and Recovery
- Relieve the traction on the extra ocular muscles and return the eye to a neutral position. While doing so, make sure to push the gelfoam down into the orbit of the eye to ensure that as the eye is rotated back into place, the gelfoam remains around the optic nerve stump. Return the lacrimal gland and extra ocular muscles to their natural positions.
- Return the flap of skin to the midline and suture the wound. Apply ophthalmic eye ointment to both eyes. Then, turn off the isoflurane source and allow the animal to breath oxygen for several minutes. Place the animal in a heated cage or a cage underneath a heat lamp to recover. Do not place any bedding in the recovery cage to eliminate the chance of aspirating bedding during recovery.
- Animals should be housed independently after surgery. Post surgical analgesics should be administered according to the guidelines of your animal care authorities, and animals should be carefully monitored after surgery.
6. Representative Results:
Transection of the optic nerve results in the loss of 90% of injured RGCs within 14 days postaxotomy 9-11. The main mechanism of RGC death is apoptosis 9, 12. The normal density of RGCs is approximately 2500 cells/mm2. Epifluorescence or confocal imaging can be used to visualize retrogradely labeled RGCs after axotomy. RGC apoptosis is delayed by approximately 4 days after axotomy, leaving a time window for experimental manipulations. At 1 day after axotomy and retrograde labeling with Fluorogold, RGC cell bodies in the ganglion cell layer of the retina and axon fascicles in the nerve fiber layer of the retina are clearly visible when imaging a flatmounted preparation (Fig 1a). By 14 days after axotomy, the majority of RGCs have died, and a few remaining RGCs are interspersed between retinal microglia (Fig 1b). When RGCs undergo apoptosis, microglia phagocytose the dead cells and as a result become transcellularly labeled with the fluorescent tracer that was used to label the RGCs 13, 14. The appearance of the tracer in the phagosomes of microglia is different from that in surviving RGCs. Microglia contain the tracer in highly concentrated and extremely bright phagosomes that are relatively large and scattered throughout their cytoplasm (Fig 1c). RGCs have a more diffuse pattern of staining (Fig 1c) with small punctate vesicles that have been retrogradely transported down their axons filing the cell cytoplasm. These vesicles are much smaller and have less intense fluorescence allowing one to differentiate surviving RGCs from microglia. Furthermore, microglia have much smaller cell bodies and tend to have a stellate or amoeboid morphology as opposed to RGCs that have relatively large and rounded cell bodies. The dendritic trees of RGCs can also help differentiate them from the short bright processes of microglia, when quantifying cell survival. Cell survival can be quantified in different regions of the retina and the density (cells/mm2) can be extrapolated from the area of the corresponding micrographs, since RGCs are found in a monolayer within the ganglion cell layer.
Figure 1. Epifluorescence micrographs of Fluorogold labeled RGCs after axotomy and application of the tracer to the optic nerve stump. (A) 1 day after axotomy RGCs and their axon fascicles are labeled with the tracer in a fine punctate manner. (B) By 14 days after axotomy, 90% of RGCs have died and brightly labeled microglia that have phagocytosed dead cells are also labeled with the tracer. (C) Higher magnification illustrating the difference between RGCs and microglia (red arrowheads) at 14 days postaxotomy. Scale bar in A and B is 50 μm. Scale bar in C is 25 μm.
There are many variations of this surgical procedure and several of the steps in this protocol are not necessary. It is only necessary to retract the muscles that overlie the optic nerve in order to gain access to the nerve. However, this results in a very limited working space around the nerve making the critical final stages of transection more difficult. In certain situations it is desirable to transfect the cells from the optic nerve stump and the increased access space afforded by retracting all of the extraocular muscles and the lacrimal gland is beneficial in this instance.
The most critical steps in the protocol are Steps 4.3-4.6. It is important not to damage the vasculature around the optic nerve head. The nerve should be transected 1.5-2.0 mm from the back of the eye in order to avoid any damage to the ophthalmic artery which penetrates the nerve within one millimeter of the eye and feeds blood to the inner retina. Thus, by maintaining a small working distance from the back of the eye damage to the ophthalmic artery can be avoided. The retina is normally transparent and blood vessels can be clearly demarcated. If the retinal blood supply is damaged the retina will degenerate leading to a milky-white flocculent appearance. The vitreous chamber of the eye and the lens will typically cloud over as well, with the eye shrinking in size over time.
With practice, all of the steps in the full surgical procedure can be accomplished in 10-15 minutes per eye, once the initial entry cuts have been made. The procedure can also be accomplished from a lateral approach to the orbit and either route is highly amenable to procedural modifications based on the preferences of the researcher. This model has a highly reproducible time course of cell death and there are several ways to target the retina globally or to directly target injured RGCs in order to test the effects of experimental treatments on cell survival.
No conflicts of interest declared.
PDK is supported by a CIHR operating grant (MOP 86523)
|Stereotaxic Frame||Stoelting Co.|
|Rat Gas Mask||Stoelting Co.|
|Isoflurane (PrAErrane)||Baxter Internationl Inc.||DIN 02225875|
|Surgical Microscope||WPI, Zeiss, Leica|
|Fluorogold -(Hydroxystilbamidine bis(methanesulfonate)||Sigma-Aldrich||39286|
|Gelfoam||Pharmacia Corporation (Pfizer)|
|Tears Naturale P.M.||Alcon|
|Vannas spring scissors||Fine Science Tools||15000-00|
|Fine tip Dumont forceps||Fine Science Tools||11252-00|
|Micro surgical hook||Fine Science Tools||10062-12|
|Eye dressing serrated forceps||Fine Science Tools||11152-10|
|Dumont #7b sharp curved serrated forceps||Fine Science Tools||11270-20|
|Cauterizer||Fine Science Tools||18010-00|
- Bahr, M. Live or let die - retinal ganglion cell death and survival during development and in the lesioned adult CNS. Trends Neurosci. 23, 483-4890 (2000).
- Isenmann, S., Kretz, A., Cellerino, A. Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog Retin Eye Res. 22, 483-543 (2003).
- Koeberle, P. D., Bahr, M. Growth and guidance cues for regenerating axons: where have they gone. J Neurobiol. 59, 162-180 (2004).
- Weishaupt, J. H., Bahr, M. Degeneration of axotomized retinal ganglion cells as a model for neuronal apoptosis in the central nervous system - molecular death and survival pathways. Restor. Neurol. Neurosci. 19, 1-2 (2001).
- Valenzuela, G. arcia, E, S. C. S. harma Rescue of retinal ganglion cells from axotomy-induced apoptosis through TRK oncogene transfer. Neuroreport. 9, 3165-3170 (1998).
- Kugler, S. Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: an in vivo model system for the inhibition of neuronal apoptotic cell death. Gene Ther. 6, 1759-1767 (1999).
- Lingor, P. Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo. Brain. 128, 550-558 (2005).
- Koeberle, P. D., Gauldie, J., Ball, A. K. Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells. Neuroscience. 125, 903-920 (2004).
- Berkelaar, M. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 14, 4368-4374 (1994).
- Villegas-Perez, M. P. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J Neurosci. 8, 265-280 (1988).
- Villegas-Perez, M. P. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol. 24, 23-36 (1993).
- Quigley, H. A. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 36, 774-786 (1995).
- Thanos, S. Specific transcellular carbocyanine-labelling of rat retinal microglia during injury-induced neuronal degeneration. Neurosci Lett. 127, 108-1012 (1991).
- Thanos, S. Specific transcellular staining of microglia in the adult rat after traumatic degeneration of carbocyanine-filled retinal ganglion cells. Exp Eye Res. 55, 101-117 (1992).